SCHEMBL3568181

SCHEMBL3568181

OC[C@@H]1CCCN1CCOc1ccc2c(C3CCNCC3)ncnc2c1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
AURKA O14965 8/20 0.45
MCHR1 Q99705 3/20 0.42
CHRM1 P11229 1/20 0.42
HTR2A P28223 1/20 0.42
HRH3 Q9Y5N1 2/20 0.40
ESR1 P03372 4/20 0.40
ESRRG P62508 2/20 0.40
ESR2 Q92731 2/20 0.40
MAPK7 Q13164 1/20 0.38
AURKB Q96GD4 6/20 0.38
CHEK1 O14757 1/20 0.37
SPHK2 Q9NRA0 1/20 0.37
CYP3A4 P08684 2/20 0.36
CYP2D6 P10635 2/20 0.36
KCNH2 Q12809 2/20 0.36
RPS6KB1 P23443 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3568186 1.00 AURKA (0.45) AURKAMCHR1CHRM1HTR2AHRH3
SCHEMBL3574113 0.95 AURKA (0.49) AURKAHRH3AURKBCHEK1RPS6KB1
SCHEMBL3574118 0.95 AURKA (0.49) AURKAHRH3AURKBCHEK1RPS6KB1
SCHEMBL5604728 0.87 MAPK7 (0.45) AURKAMCHR1CHRM1HTR2AHRH3
SCHEMBL4965317 0.87 MAPK7 (0.45) AURKAMCHR1CHRM1HTR2AHRH3
SCHEMBL13034745 0.85 MCHR1 (0.42) AURKAMCHR1CHRM1HTR2AHRH3
SCHEMBL3564760 0.83 HRH3 (0.51) AURKAHRH3ESR1ESR2AURKB
SCHEMBL5006918 0.83 AURKA (0.49) AURKAHRH3MAPK7AURKBRPS6KB1
SCHEMBL5137699 0.83 AURKA (0.49) AURKAHRH3MAPK7AURKBRPS6KB1
SCHEMBL3568546 0.81 MAPK7 (0.40) AURKAMAPK7AURKBCHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7825244-B2 Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators, and related methods of synthesis JANSSEN PHARMACEUTICA NV (BE) 2010-11-02 US disclosed
US-7825244-B2 Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators, and related methods of synthesis JANSSEN PHARMACEUTICA NV (BE) 2010-11-02 US disclosed
US-7825244-B2 Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators, and related methods of synthesis JANSSEN PHARMACEUTICA NV (BE) 2010-11-02 US disclosed
US-20070021436-A1 INTERMEDIATES USEFUL IN THE SYNTHESIS OF ALKYLQUINOLINE AND ALKYLQUINAZOLINE KINASE MODULATORS, AND RELATED METHODS OF SYNTHESIS JANSSEN PHARMACEUTICA, N.V. (BE) 2007-01-25 US disclosed
US-20070021436-A1 INTERMEDIATES USEFUL IN THE SYNTHESIS OF ALKYLQUINOLINE AND ALKYLQUINAZOLINE KINASE MODULATORS, AND RELATED METHODS OF SYNTHESIS JANSSEN PHARMACEUTICA, N.V. (BE) 2007-01-25 US disclosed
US-20070021436-A1 INTERMEDIATES USEFUL IN THE SYNTHESIS OF ALKYLQUINOLINE AND ALKYLQUINAZOLINE KINASE MODULATORS, AND RELATED METHODS OF SYNTHESIS JANSSEN PHARMACEUTICA, N.V. (BE) 2007-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021436-A1 INTERMEDIATES USEFUL IN THE SYNTHESIS OF ALKYLQUINOLINE AND ALKYLQUINAZOLINE KINASE MODULATORS, AND RELATED METHODS OF SYNTHESIS FLT3, ABL1, KIT AURKA 135/4885MCHR1 1470/4885CHRM1 1033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.